Literature DB >> 3034420

Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer.

H L Bradlow, R E Hershcopf, J F Fishman.   

Abstract

17-oxidation and 2- and 16 alpha-hydroxylation of oestradiol show important correlations with biological aspects of breast cancer in women and mice. The presence of mouse mammary tumour virus may lead to increased 16 alpha-hydroxylation. 16 alpha-hydroxyoestrone (which may be generated in an autocrine manner) forms covalent linkages with amino groups on proteins and nucleotides.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3034420

Source DB:  PubMed          Journal:  Cancer Surv        ISSN： 0261-2429


  9 in total

1.  Potential applications of salivary steroid immunoassays for investigations of cancer of reproductive tissues.

Authors:  P F Fottrell
Journal:  Br J Cancer Suppl       Date:  1988-12

Review 2.  Estrogen metabolism and breast cancer.

Authors:  Hamed Samavat; Mindy S Kurzer
Journal:  Cancer Lett       Date:  2014-04-28       Impact factor: 8.679

3.  Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women.

Authors:  Renée T Fortner; Susan E Hankinson; Catherine Schairer; Xia Xu; Regina G Ziegler; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-27       Impact factor: 4.254

4.  Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".

Authors:  MaryFran R Sowers; John Randolph; Mary Jannausch; Bill Lasley; Elizabeth Jackson; Daniel McConnell
Journal:  Arch Intern Med       Date:  2008-10-27

Review 5.  Contraceptive steroids and the mammary gland: is there a hazard?--Insights from animal studies.

Authors:  G R Rutteman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 6.  Perinatal factors increase breast cancer risk.

Authors:  L Hilakivi-Clarke; R Clarke; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  Sex steroid hormones, bone mineral density, and risk of breast cancer.

Authors:  L H Kuller; J A Cauley; L Lucas; S Cummings; W S Browner
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

9.  Urinary estrogen levels in women on contraceptives in enugu, South-East Nigeria.

Authors:  Ignatius C Maduka; Francis E Ezeonu; Emeka E Neboh; Elvis N Shu; Ebele J Ikekpeazu
Journal:  J Family Med Prim Care       Date:  2012-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.